Actual Impact of COVID-19 on CRC (8.7% Reduction) and Advanced Adenoma (26.9% Reduction) Diagnoses in a U.S. Health Care System
Douglas K. Rex, MD, MASGE, reviewing Lee JK, et al. Gastroenterology 2022 May 14.
This study utilized the Kaiser Permanente Northern California (KPNC) health care system to evaluate the actual impact of the COVID-19 pandemic on colorectal cancer (CRC). This health care system, which primarily uses mailed fecal immunochemical test (FIT) kits for CRC screening, halted mailings of FIT kits in March and April 2020. KPNC also paused most elective colonoscopies in those months, but it had ramped back up to full performance by September 2020.
In total, in 2020 compared with 2019, there was an eventual 8.7% increase in mailed FIT kits (in response to decreased availability of elective colonoscopy services) but 9% fewer FITs completed and 10.1% fewer positive tests. Total colonoscopies were down 26.9% in 2020, and there was an 8.7% reduction in CRC cases diagnosed and a 26.9% reduction in diagnoses of advanced adenoma.
Note to readers: At the time we reviewed this paper, its publisher noted that it was not in final form and that subsequent changes might be made.
CITATION(S)
Lee JK, Lam AY, Jensen CD, et al. Impact of the COVID-19 pandemic on fecal immunochemical testing, colonoscopy services, and colorectal neoplasia detection in a large United States community-based population. Gastroenterology 2022 May 14. (Epub ahead of print) (https://doi.org/10.1053/j.gastro.2022.05.014)